CONTROLLED CLINICAL-TRIAL OF THE EFFECT OF ASPIRIN AND ASPIRIN + DIPYRIDAMOLE ON THE DEVELOPMENT OF DIABETIC-RETINOPATHY .2. OPHTHALMOLOGIC PROTOCOL

被引：0
|
作者：
不详
机构：
来源：
DIABETES & METABOLISM | 1982年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：307 / 311
页数：5
相关论文
共 50 条
  • [21] Aspirin for diabetic retinopathy - The evidence of a beneficial effect is from basic science, not clinical trials
    Kohner, EM
    BRITISH MEDICAL JOURNAL, 2003, 327 (7423): : 1060 - 1061
  • [22] A comparative Randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy
    Khajehdehi, P
    Roozbeh, J
    Mostafavi, H
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2002, 36 (02): : 145 - 148
  • [23] AICLA CONTROLLED TRIAL OF ASPIRIN AND DIPYRIDAMOLE IN THE SECONDARY PREVENTION OF ATHERO-THROMBOTIC CEREBRAL-ISCHEMIA .2. BASELINE STUDIES
    BOUSSER, MG
    ESCHWEGE, E
    HAGUENAU, M
    LEFAUCONNIER, JM
    THIBULT, N
    TOUBOUL, D
    TOUBOUL, PJ
    REVUE NEUROLOGIQUE, 1982, 138 (01) : 1 - 15
  • [24] ASPIRIN EFFECTS ON THE DEVELOPMENT OF CATARACTS IN PATIENTS WITH DIABETES-MELLITUS - EARLY TREATMENT DIABETIC-RETINOPATHY STUDY REPORT .16.
    CHEW, EY
    WILLIAMS, GA
    BURTON, TC
    BARTON, FB
    REMALEY, NA
    FERRIS, FL
    ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (03) : 339 - 342
  • [25] AICLA CONTROLLED TRIAL OF ASPIRIN AND DIPYRIDAMOLE IN THE SECONDARY PREVENTION OF ATHERO-THROMBOTIC CEREBRAL-ISCHEMIA .1. PROTOCOL
    BOUSSER, MG
    ESCHWEGE, E
    HAGUENAU, M
    LEFAUCONNIER, JM
    TOUBOUL, D
    TOUBOUL, PJ
    REVUE NEUROLOGIQUE, 1981, 137 (05) : 333 - 341
  • [26] LOW-DOSE ASPIRIN THERAPY FOR CHRONIC STABLE ANGINA - A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL-TRIAL
    RIDKER, PM
    MANSON, JE
    GAZIANO, JM
    BURING, JE
    HENNEKENS, CH
    ANNALS OF INTERNAL MEDICINE, 1991, 114 (10) : 835 - 839
  • [27] Double-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial
    Chen, Mu
    Wang, Qunshan
    Sun, Jian
    Zhang, Peng-Pai
    Li, Wei
    Mo, Bin-Feng
    Chen, Tai-Zhong
    Tang, Xiaoli
    Li, Yi-Gang
    BMJ OPEN, 2021, 11 (03):
  • [28] DESIGN OF A PLACEBO-CONTROLLED CLINICAL-TRIAL OF LONG-ACTING DILTIAZEM AND ASPIRIN VERSUS ASPIRIN ALONE IN PATIENTS RECEIVING THROMBOLYSIS WITH A FIRST ACUTE MYOCARDIAL-INFARCTION
    BODEN, WE
    SCHELDEWAERT, R
    WALTERS, EG
    WHITEHEAD, A
    COLTART, DJ
    SANTONI, JP
    BELGRAVE, G
    STARKEY, IR
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (16): : 1120 - 1123
  • [29] ASSESSING POSSIBLE LATE TREATMENT EFFECTS IN STOPPING A CLINICAL-TRIAL EARLY - A CASE-STUDY - DIABETIC-RETINOPATHY STUDY REPORT NO 9
    EDERER, F
    PODGOR, MJ
    CONTROLLED CLINICAL TRIALS, 1984, 5 (04): : 373 - 381
  • [30] FIBRINOLYTIC-ACTIVITY AFTER ADMINISTRATION OF DIFLUNISAL AND ASPIRIN - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL-TRIAL
    GREEN, D
    DAVIES, RO
    HOLMES, GI
    JOHNSON, C
    KOHL, H
    REYNOLDS, N
    TSAO, CH
    HAEMOSTASIS, 1983, 13 (06) : 394 - 398
12345